… of NOACs in elderly patients. We focus on subgroup analyses of the phase 3 randomized
controlled trials in which the NOACs were compared with VKAs in patients with VTE or AF. …

… oral anticoagulants in elderly patients. … , anticoagulant treatment, especially in elderly
patients, should be based on an evaluation of the risk/benefit balance on a careful patientby-patient …

… of anticoagulation is one of the most challenging issues in the individual elderly patient,
patients … Thus, whenever prescribing oral anticoagulation is decided in elderly patients, special …

… The results from this study could increase physician confidence in prescribing oral anticoagulants
for elderly patients. It could also serve as a hypothesis generator for RCTs comparing …

… In the last decade, efforts have been made to better understand the inter-individual
variability in the response of elderly patients to traditional anticoagulants including heparin …

… of oral anticoagulation is the highest in elderly patients in whom it outweighs the risk of
bleeding. Direct oral anticoagulants (… with warfarin, elderly patients often remain undertreated …

… bleeding, particularly in frail patients, in whom numerous … of oral anticoagulants (OACs). AF
trials showed that the relative benefits of direct OACs (DOACs) also applied to elderly patients…

… in elderly individuals. Clinical practice guidelines recommend the long-term use of oral
anticoagulation in elderly patients … only oral anticoagulants available, but using warfarin in elderly …

… When no specific contraindications are present, elderly patients with either paroxysmal or
persistent NVAF should be considered candidates for treatment with anticoagulants. Pooled …

… Oral anticoagulants may still be considered as thromboprophylaxis for elderly patients,
with nonvitamin K antagonist oral anticoagulants being the more favorable choice. …